… No molecular markers exist that can predict the toxicity of PRRT. Candidate molecular …
are tumour-specific, might yield molecular tools to enhance the efficacy and safety of PRRT. …

… In summary, pancreatic cancer remains a disease with poor long-… pancreatic cancer
treatment and the milestones that brought us to where we are today, along with emerging therapies…

… therapeutic effect of these drugs is not as expected. Therefore, it is necessary to find a novel
therapy … insulin sensitivity, reduce weight and maintain the activity of pancreatic beta cells. …

… therapies, active research avenues explore the development of novel therapeutics that target
the crosstalk between cancer and … In this review, we discuss the therapeutic opportunities …

… Inhibition of SGLT2 promotes glycosuria and represents a novel therapeutic strategy for
treating T2DM. Three SGLT2i are currently in clinical use; dapagliflozin, canagliflozin, and …

… cancer as regards to different therapies and cancer types. Finally, we propose a small molecule
dual-targeting broad-spectrum anticancer strategy … , especially at the micro-cancer stage. …

… tumor survival [79]. Clarifying the impact of the dynamic CAF environment on tumor growth
and metastasis may inform novel treatment strategies targeting specific CAF populations. …

… of PR expression, we observed that HG tumors, which have a worse prognosis, … endocrine
therapy in breast and other cancers, thus our findings may lead to a novel treatment strategy …

… cancer is a heterogeneous disease that is driven by genetic, … article we review genetic and
non-genetic causes of tumor … heterogeneity has on resistance to therapy. We will provide …

… , demanding novel treatment strategies such as immune checkpoint inhibition in tumors with
… of 10) but highly infrequent in neuroendocrine neoplasms from many other sites. The lack of …